Latest / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Teplizumab, Stelo, and Inhaled Insulin Afrezza for Pediatric Patients
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss a series of major pediatric diabetes advancements announced around the American Diabetes Association (ADA) Scientific Sessions 2026, highlighting how recent regulatory decisions are expanding treatment options and improving access to diabetes technologies.The conversation opens with the expanded FDA indication for teplizumab in children and adolescents with newly diagnosed stage 3 type 1 diabetes. Bellini reviews findings from…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.